Chronic obstructive pulmonary disease management among primary healthcare physicians

Monaldi Archives for Chest Disease

Volumn 55, Issue 3, 2000, Pages 201-204

  Trakada, G ^a   Spiropoulos, K ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Chronic obstructive pulmonary disease; Guidelines; Physicians; Primary care

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CEPHALOSPORIN DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IMMUNOSTIMULATING AGENT; INFLUENZA VACCINE; MACROLIDE; MUCOLYTIC AGENT; QUINOLONE DERIVATIVE; THEOPHYLLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; GREECE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0033868893     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
3. The definition of emphysema, report of a National Heart, Lung and Blood Institute, division of lung diseases
4. Management of chronic obstructive pulmonary disease
5. Therapeutic algorithm for chronic obstructive pulmonary disease
6. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: ATS statement
7. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS
8. Regular source of ambulatory care and access to health services
9. Course and prognosis in patients with chronic airflow obstruction: Possible implications for therapy
10. Interpretation of bronchodilator response in patients with obstructive airways disease
11. Bronchodilator response in chronic obstructive pulmonary disease
12. Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction
13. Bronchodilator responses to anticholinergic and β-adrenergic agents in acute and stable COPD
14. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial
15. A randomized, controlled trial of theophylline in patients with severe chronci obstructive pulmonary disease
16. Inflammation in bronchial biopsies of subjects with chronic bronchitis: Inverse relationship of CD8+ T-lymphocytes with FEV1
17. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters
18. The effects of chronic bronchitis and chronic airflow obstruction on lung cell population recovered by bronchoalveolar lavage
19. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study
20. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD
21. Severe exacerbations of COPD patients: The role of pulmonary infections
22. Chronic obstructive airway disease. Bacterial and cellular content of the sputum
23. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
24. Tracheobronchial function in health and disease. Effect of mucolytic substances
25. Evolution of a multicomponent group smoking cessation program